Molbio announces collaboration with UE LifeSciences to expand iBreastExam® to the global market

New Delhi: Molbio Diagnostics, an innovative point-of-care diagnostics company, and UE LifeSciences, a Philadelphia-based innovator manufacturing health technology solutions, have announced an exclusive collaboration.

The collaboration seeks to make early breast cancer detection accessible to millions of women in over 50 countries across the developing world.

Through this collaboration, Molbio will bring UE LifeSciences’ iBreastExam® —a radiation-free, painless, and FDA-cleared screening device across India, Africa, the Middle East, CIS countries, the Philippines, Indonesia, and Vietnam.

Together, they aim to address the late detection of breast cancer, a leading cause of preventable breast cancer mortality. Molbio Diagnostics will leverage its global distribution network and expertise in expanding access to healthcare solutions to promote, market, sell, and distribute the iBreastExam® to public and private healthcare providers in these regions.